Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) - Share price - Overview

Stock Report

Alnylam Pharmaceuticals Inc ALNY

Last Price
$98.96

Day Change
-1.84|-1.83%

As of 22/05/2018
17:06:58 EDT | USD
Minimum 15 Minutes Delay.

Last Close100.80
Day Range98.69 - 101.57
Mkt Cap9.95Bil
52-Wk Range62.96 - 153.99
Yield %-
ISINUS02043Q1076
Volume544,270
P/E-17.73
P/S100.00
P/CF-21.24

Share Price

Financials
201520162017
More ...
Income Statement
Revenue41.1047.1689.91
Operating Income-296.01-424.59-500.09
Net Income-290.07-410.11-490.87
Basic EPS-3.45-4.79-5.42
Avg. Diluted Shares Outstanding848691
Balance Sheet
Current Assets1,105.39671.881,764.74
Non Current Assets281.12590.93229.99
Total Assets1,386.511,262.811,994.73
Current Liabilities62.10131.70144.25
Total Liabilities---
Total Equity1,264.71920.221,766.43
Cash Flow
Operating Cash Flow-189.14-307.70-382.79
Capital Expenditure-12.95-64.56-104.21
Free Cash Flow-202.09-372.26-487.00

In millions, except "Basic EPS". Currency is USD.

Company Profile

Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Mid-Growth

Fiscal Year Ends

December

Employees

749
Key Stats
More ...
Price/Earning TTM-18.06
Price/Book5.77
Price/Sales TTM101.52
Rev Growth (3 year avg)21.15
EPS Growth (3 year avg)-
Operating Margin % TTM-556.20
Net Margin % TTM-545.95
ROE TTM-36.54
Debt/Equity0.02
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.